HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stijn W van Beek Selected Research

Stijn W van Beek Research Topics

Disease

2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
12/2022 - 01/2022
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2022
2Tuberculosis (Tuberculoses)
10/2021 - 01/2019
2Pulmonary Tuberculosis
07/2021 - 01/2021
1Exanthema (Rash)
01/2022
1Anemia
10/2021
1Glucosephosphate Dehydrogenase Deficiency
10/2021
1Hemolysis
10/2021
1Malaria
10/2021
1Burns
01/2020
1Critical Illness (Critically Ill)
01/2020

Drug/Important Bio-Agent (IBA)

3bedaquiline (R207910)IBA
12/2022 - 10/2021
2brigatinibIBA
01/2022 - 01/2022
2Rifampin (Rifampicin)FDA LinkGeneric
10/2021 - 01/2019
2Isoniazid (Ftivazide)FDA LinkGeneric
07/2021 - 01/2021
1Clofazimine (Lamprene)FDA Link
12/2022
1AmylasesFDA Link
01/2022
1Anaplastic Lymphoma KinaseIBA
01/2022
1PrimaquineFDA Link
10/2021
1artemisinin (artemisinine)IBA
10/2021
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
10/2021
1Hemoglobins (Hemoglobin)IBA
10/2021
1Amikacin (A.M.K)FDA LinkGeneric
01/2020
1PiperacillinFDA LinkGeneric
01/2020
1Pharmaceutical PreparationsIBA
01/2019

Therapy/Procedure

1Mass Drug Administration
10/2021
1Therapeutics
10/2021